Effects of a Warm-up on Immune Response to Exercise

May 16, 2022 updated by: Emily C Lavoy, University of Houston

The Effects of a Dynamic Warm up on the Immune Response to Exercise in Lower Fit and Higher Fit Adults

This randomized cross-over study compares two identical cardiorespiratory exercise bouts, differing only in the inclusion or exclusion of a dynamic period of increasing exercise intensity prior to the exercise bout. Planned comparisons include physiological responses and perceived effort during exercise, leukocyte mobilization, and mood between the two exercise sessions.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Physically active adult men and women are asked to complete three study visits to the laboratory. On Visit 1, participants provide informed consent and are screened for study inclusion criteria: being between 18 and 40 years of age, a non-smoker, not pregnant, free of disease impacting exercise performance or immunity, and performing at least one hour per week of vigorous exercise training (any modality) for at least the prior six months. Participants also complete an incremental submaximal exercise test on a stationary bicycle. The results of this test are used to calculate the resistance corresponding to 80% of estimated maximal heart rate. Participants return within 2-14 days for Visits 2 and 3. These visits consist of 30 min of bicycling at this resistance. One visit included a 10 min dynamic warm-up prior to the exercise bout. Participants were stratified by sex and randomized such that half of the men and women completed the exercise trial with warm-up during Visit 2.

Heart rate, perceived exertion, and wattage are recorded during each minute of the exercise bouts. Participants donate blood before, immediately after, and 1h after each exercise. Blood is analyzed by flow cytometry to characterize leukocyte subsets. After each exercise session, participants complete surveys assessing mood and affect.

Physiological, immunological, and psychological parameters recorded will be compared within participants between the two experimental exercise sessions using appropriate statistical tests. p<0.05 will be accepted as significant.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77204
        • University of Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • identifies as exercising 1-3 hours per week or more than 6 hours per week, on average (last 6 months)
  • meets American College of Sports Medicine criteria for participation in exercise

Exclusion Criteria:

  • underlying medical problems that contraindicate supervised high intensity exercise
  • past or present history of autoimmune disease, HIV, hepatitis, stroke, or cardiovascular disease
  • chronic/debilitating arthritis
  • central or peripheral nervous disorders
  • asthma, emphysema, or bronchitis
  • bedridden in the past three months
  • history of blood clotting disorders
  • administration of any medication that might affect physiological response to exercise
  • functional or cognitive impairment that would limit exercise performance or prohibit informed consent
  • having any common-cold or influenza like symptoms (scratchy throat, runny nose, inflamed sinuses, frequent sneezing or coughing) in the last 2 weeks
  • pregnancy
  • tobacco use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Warm-up, then no warm-up
Participants' visit 2 included 10 minutes of gradually increasing intensity prior to the 30 minute exercise session. Participants' visit 3 consisted of the 30 minute exercise session without a warm-up.
30 minutes of exercise at 80% of maximum predicted heart rate performed on an indoor stationary bicycle. Exercise was preceded by 10 min of gradually increasing cycling intensity in one of two exercise trials
Other Names:
  • Cardiorespiratory exercise
Experimental: No warm-up, then warm-up
Participants' visit 2 consisted of the 30 minute exercise session without a warm-up. Participants' visit 3 included 10 minutes of gradually increasing intensity prior to the 30 minute exercise session.
30 minutes of exercise at 80% of maximum predicted heart rate performed on an indoor stationary bicycle. Exercise was preceded by 10 min of gradually increasing cycling intensity in one of two exercise trials
Other Names:
  • Cardiorespiratory exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate during exercise
Time Frame: Minutes 1-30 of exercise, recordings made each minute
Heart rate in beats per minute
Minutes 1-30 of exercise, recordings made each minute
Perceived exertion during exercise
Time Frame: Minutes 1-30 of exercise, recordings made each minute
Rating of perceived exertion measured using the Borg 6-20 scale
Minutes 1-30 of exercise, recordings made each minute
Power during exercise
Time Frame: Minutes 1-30 of exercise, recordings made each minute
Wattage produced on stationary bicycle
Minutes 1-30 of exercise, recordings made each minute
Monocyte mobilization by exercise
Time Frame: Change from resting levels of monocytes after exercise
Number of peripheral blood monocytes
Change from resting levels of monocytes after exercise
Natural Killer cell mobilization by exercise
Time Frame: Change from resting levels of natural killer cells after exercise
Number of peripheral blood natural killer cells
Change from resting levels of natural killer cells after exercise
CD4 T cell mobilization by exercise
Time Frame: Change from resting levels of CD4 T cells after exercise
Number of peripheral blood CD4 T cells
Change from resting levels of CD4 T cells after exercise
CD8 T cell mobilization by exercise
Time Frame: Change from resting levels of CD8 T cells after exercise
Number of peripheral blood CD8 T cells
Change from resting levels of CD8 T cells after exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mood after exercise
Time Frame: Measured within 10 minute of end of exercise session
Mood dimensions characterized by Profile of Mood Survey
Measured within 10 minute of end of exercise session
Affect after exercise
Time Frame: Measured within 10 minute of end of exercise session
Affect characterized by Positive and Negative Affect Schedule
Measured within 10 minute of end of exercise session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily C LaVoy, PhD, University of Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2018

Primary Completion (Actual)

February 1, 2020

Study Completion (Actual)

September 30, 2021

Study Registration Dates

First Submitted

April 25, 2021

First Submitted That Met QC Criteria

April 27, 2021

First Posted (Actual)

April 30, 2021

Study Record Updates

Last Update Posted (Actual)

May 17, 2022

Last Update Submitted That Met QC Criteria

May 16, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00000990

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All individual participant data that underlie results in a publication will be made available upon request

IPD Sharing Time Frame

Will be available upon publication

IPD Sharing Access Criteria

Requests should be sent to and will be reviewed by the principle investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physiological and Psychological Responses to Exercise

Clinical Trials on Exercise

Subscribe